Deutsche Bank’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $199K | Buy |
45,062
+4,181
| +10% | +$22.6K | ﹤0.01% | 3007 |
|
|
2025
Q4 | $260K | Buy |
40,881
+1,770
| +5% | +$12.3K | ﹤0.01% | 2890 |
|
|
2025
Q3 | $365K | Buy |
39,111
+5,281
| +16% | +$53.3K | ﹤0.01% | 2714 |
|
|
2025
Q2 | $487K | Buy |
33,830
+12,204
| +56% | +$121K | ﹤0.01% | 2468 |
|
|
2025
Q1 | $149K | Sell |
21,626
-5,252
| -20% | -$33K | ﹤0.01% | 3075 |
|
|
2024
Q4 | $143K | Buy |
26,878
+25,412
| +1,733% | +$139K | ﹤0.01% | 3201 |
|
|
2024
Q3 | $5.35K | Hold |
1,466
| – | – | ﹤0.01% | 3530 |
|
|
2024
Q2 | $4K | Buy |
+1,466
| New | +$4.91K | ﹤0.01% | 3501 |
|
|
2022
Q2 | – | Sell |
-26,525
| Closed | -$66K | – | 4377 |
|
|
2022
Q1 | $66K | Sell |
26,525
-3,018
| -10% | -$8.25K | ﹤0.01% | 3744 |
|
|
2021
Q4 | $110K | Buy |
29,543
+1,502
| +5% | +$8.11K | ﹤0.01% | 3668 |
|
|
2021
Q3 | $176K | Sell |
28,041
-866
| -3% | -$7.14K | ﹤0.01% | 3633 |
|
|
2021
Q2 | $285K | Sell |
28,907
-154,955
| -84% | -$1.35M | ﹤0.01% | 3577 |
|
|
2021
Q1 | $1.72M | Buy |
183,862
+99,655
| +118% | +$790K | ﹤0.01% | 2288 |
|
|
2020
Q4 | $404K | Buy |
84,207
+5,798
| +7% | +$28.3K | ﹤0.01% | 3052 |
|
|
2020
Q3 | $314K | Buy |
78,409
+19,858
| +34% | +$95.8K | ﹤0.01% | 2938 |
|
|
2020
Q2 | $269K | Buy |
58,551
+44,553
| +318% | +$199K | ﹤0.01% | 2984 |
|
|
2020
Q1 | $46K | Sell |
13,998
-828
| -6% | -$3.18K | ﹤0.01% | 3587 |
|
|
2019
Q4 | $63K | Sell |
14,826
-9,716
| -40% | -$34.5K | ﹤0.01% | 3849 |
|
|
2019
Q3 | $96K | Sell |
24,542
-5,399
| -18% | -$23K | ﹤0.01% | 3579 |
|
|
2019
Q2 | $139K | Sell |
29,941
-18,640
| -38% | -$79.5K | ﹤0.01% | 4043 |
|
|
2019
Q1 | $202K | Sell |
48,581
-1,719
| -3% | -$6.2K | ﹤0.01% | 3999 |
|
|
2018
Q4 | $171K | Sell |
50,300
-36,941
| -42% | -$128K | ﹤0.01% | 3960 |
|
|
2018
Q3 | $375K | Buy |
87,241
+13,394
| +18% | +$57.6K | ﹤0.01% | 3934 |
|
|
2018
Q2 | $274K | Buy |
73,847
+17,293
| +31% | +$65.7K | ﹤0.01% | 4146 |
|
|
2018
Q1 | $237K | Buy |
56,554
+33,608
| +146% | +$176K | ﹤0.01% | 4098 |
|
|
2017
Q4 | $134K | Buy |
22,946
+22,874
| +31,769% | +$124K | ﹤0.01% | 4170 |
|
|
2017
Q3 | $0 | Sell |
72
-48,055
| -100% | -$176K | ﹤0.01% | 5125 |
|
|
2017
Q2 | $183K | Buy |
48,127
+41,153
| +590% | +$130K | ﹤0.01% | 3971 |
|
|
2017
Q1 | $18K | Sell |
6,974
-11,082
| -61% | -$31.4K | ﹤0.01% | 4533 |
|
|
2016
Q4 | $58K | Buy |
18,056
+13,347
| +283% | +$36.3K | ﹤0.01% | 4312 |
|
|
2016
Q3 | $14K | Buy |
4,709
+234
| +5% | +$859 | ﹤0.01% | 4616 |
|
|
2016
Q2 | $18K | Buy |
+4,475
| New | +$21.2K | ﹤0.01% | 4783 |
|
Other funds holding NAGE
SW
VCM
TCM
